In addition, RPS6KB1 has been viewed as a potential biomarker for aggressive malignant lymphoma [48], especially in patients with HIV [49], and has also been associated with the development of multiple sclerosis in Iranian populations [50]. This evidence concerns the gene RPS6KB1 and lymphoma.